JAK2V617F drives gut microbiota differences in patients with myeloproliferative neoplasms

• DOI: 10.1111/ejh.14169
• Publication Date: 2024-01-16T13:38:53Z
• Authors: Christina Schjell...; Henrik V. Nielsen; Kurt Fuursted; Christen Rune Ste...; Lee O' Brien Ande...; Berit Lilje; Morten Kranker La...; Lasse Kjær; Sarah Friis Chris...; Trine Alma Knudsen; Vibe Skov; Anders Lindholm S...; Christina Ellervik; Lars Rønn Olsen; Jens Jørgen Elmer...; Xiaohui Chen Nielsen; Hans Carl Hasselb...; Anna Cäcilia Ingham
• Keywords: Myeloproliferative neoplasm

Essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (MF) are myeloproliferative neoplasms (MPN). Inflammation is involved in the initiation, progression, symptomology of diseases. The gut microbiota impacts immune system, infection control, steady-state hematopoiesis.